For example, muscle biopsies obtained from DMD patients often have a lower muscle fiber content and more fibrotic or fatty tissue than in healthy donor biopsies, resulting in lower levels of non-skipped dystrophin expression and potentially hampering reliable quantification of exon skip levels. This evidence concerns the gene DMD and Duchenne muscular dystrophy.